Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 54

Sort by

Sort Order Select

Journal Articles

High Incidence of Severe TA-TMA Increases Mortality in adult Allogeneic Transplant recipients: A prospective MIDAS Consortium study

Sumithira Vasu, Qiuhong Zhao, Elizabeth Greer Miller, Patrick Elder, Lucille Langenberg, Spero R. Cataland, Stella M Davies, Nelli Bejanyan, Theresa Hahn

Blood blood.2025028390.

https://doi.org/10.1182/blood.2025028390

Published: 2025

Includes: Supplemental data

Journal Articles

A Phase I Study to Evaluate the Safety and Tolerability of Gemtuzumab Ozogamicin and Midostaurin When Used in Combination with Standard Cytarabine and Daunorubicin Induction for Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia

Uma Borate, Kaitlyn M. Dvorak-Kornaus, Qiuhong Zhao, Roland B. Walter, Rachel J. Cook, Jennifer N. Saultz, Ronan T. Swords, Nicole R. Grieselhuber, Alice Mims, Karilyn T. Larkin, Kieran D Sahasrabudhe, James S. Blachly, Gregory K Behbehani, Ann-Kathrin Eisfeld, Meixiao Long, Andrew Srisuwananukorn, Kristin L Koenig

Blood (2024) 144 (Supplement 1): 4286.

https://doi.org/10.1182/blood-2024-210605

Published: 2024

Journal Articles

Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy Is Associated with Inferior Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3747.

https://doi.org/10.1182/blood-2024-203798

Published: 2024

Journal Articles

Association between Post-CART Terminal Complement Complex Levels and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)

Blood (2024) 144 (Supplement 1): 3446.

https://doi.org/10.1182/blood-2024-198872

Published: 2024

Journal Articles

Building Inroads for Transplant Access: Bridging the Gap for Underserved Patients with Multiple Myeloma

Srinivas Devarakonda, Qiuhong Zhao, Don Benson, Francesca Cottini, Abdullah Mohammad Khan, Elvira Umyarova, Naresh Bumma, Nowshin Islam, Nidhi Sharma, Jessica Krok-Schoen, James L Fisher, Jesse J Plascak, Electra D Paskett, Ashley Rosko

Blood (2024) 144 (Supplement 1): 7865.

https://doi.org/10.1182/blood-2024-211200

Published: 2024

Journal Articles

Extended Follow up of a Phase 2 Study of Early Intervention with Lenalidomide in Patients with High-Risk Chronic Lymphocytic Leukemia

Kerry A Rogers, Qiuhong Zhao, Seema A Bhat, John C. Byrd, Cara Grantier, Michael R. Grever, Corinne Hoffman, Adam S Kittai, Gerard Lozanski, Margaret S. Lucas, Lindsey Rike, Shanmugapriya Thangavadivel, William E. Carson III, Jennifer A. Woyach

Blood (2023) 142 (Supplement 1): 3272.

https://doi.org/10.1182/blood-2023-180308

Published: 2023

Journal Articles

Deletion 1p at Time of Diagnosis of Multiple Myeloma Portends Inferior Outcomes

Arti Vaishnav, Abdullah Khan, Qiuhong Zhao, Naresh Bumma, Francesca Cottini, Elvira Umyarova, Nidhi Sharma, Ashley E Rosko, Don Benson, Srinivas Devarakonda

Blood (2023) 142 (Supplement 1): 1974.

https://doi.org/10.1182/blood-2023-182845

Published: 2023

Journal Articles

A Randomized Double-Blind Placebo-Controlled Phase II Multi-Center Study of Inflammation Modification of Canakinumab to Prevent Leukemic Progression of Clonal Cytopenias of Unknown Significance (CCUS): Impact Study

Uma M. Borate, Kaitlyn M. Dvorak-Kornaus, Qiuhong Zhao, Ann-Kathrin Eisfeld, Bethany L Mundy-Bosse

Blood (2023) 142 (Supplement 1): 1327.

https://doi.org/10.1182/blood-2023-189949

Published: 2023

Journal Articles

A Phase II Study of Clinical Efficacy of Venetoclax in Combination with Azacitidine in Patients with Therapy Related Myelodysplastic Syndrome (t-MDS)

Uma M. Borate, Kaitlyn M. Dvorak-Kornaus, Qiuhong Zhao, Kristin L Koenig, Ann-Kathrin Eisfeld, Yazan F. Madanat

Blood (2023) 142 (Supplement 1): 6504.

https://doi.org/10.1182/blood-2023-190082

Published: 2023

Journal Articles

Efficacy of Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Toxicities - a Multicenter Retrospective Analysis

Amneet K Bajwa, Qiuhong Zhao, Marcus Johannes Geer, Agrima Mian, Chenyu Lin, David Frame, James Westholder, Justin Tossey, Monalisa Ghosh, Ahmed Galal, Nausheen Ahmed, Joseph E. Maakaron, Nathan Denlinger, Marcos de Lima, Narendranath Epperla, Paolo F. Caimi, Timothy Voorhees

Blood (2023) 142 (Supplement 1): 4502.

https://doi.org/10.1182/blood-2023-179620

Published: 2023

Journal Articles

Predictive Score for Utilization of Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Arti Vaishnav, Abdullah Khan, Qiuhong Zhao, Naresh Bumma, Francesca Cottini, Elvira Umyarova, Nidhi Sharma, Yvonne Efebera, Lynn O'Donnell, Ashley E Rosko, Sumithira Vasu, Marcos de Lima, Don Benson, Srinivas Devarakonda

Blood (2023) 142 (Supplement 1): 911.

https://doi.org/10.1182/blood-2023-184904

Published: 2023

Journal Articles

I-DATA Study: Randomized, Sequential, Open-Label Study to Evaluate the Efficacy of IDH Targeted/Non- Targeted Versus Non-Targeted/IDH-Targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated Adult AML Patients Not Candidates for Intensive Induction Therapy

Michael P Ozga, Kaitlyn M. Dvorak-Kornaus, Qiuhong Zhao, Jill Buss, Andrea Laganson, Ethan Hamp, Yazan F. Madanat, Daniel A. Pollyea, Eytan M. Stein, Joshua F. Zeidner, Elaine R Mardis, Ann-Kathrin Eisfeld, Alice Mims

Blood (2023) 142 (Supplement 1): 1534.

https://doi.org/10.1182/blood-2023-187060

Published: 2023

Journal Articles

Ventricular arrhythmias and sudden death events following acalabrutinib initiation

Seema A. Bhat, John Gambril, Leylah Azali, Sunnia T. Chen, Lindsay Rosen, Marilly Palettas, Tracy E. Wiczer, Sujay Kalathoor, Qiuhong Zhao, Kerry A. Rogers, Adam Kittai, Michael Grever, Farrukh Awan, Patrick Ruz, John C. Byrd, Jennifer Woyach, Daniel Addison

Blood (2022) 140 (20): 2142–2145.

https://doi.org/10.1182/blood.2022016953

Published: 2022

Includes: Supplemental data

Journal Articles

Incidence, Description, and Timing of Serious or Opportunistic Infections in Patients with Hairy Cell Leukemia Treated with Purine Nucleoside Analogues

Nilesh Kapoor, Qiuhong Zhao, Andrew Stiff, Seema A. Bhat, Mirela Iulia Anghelina, Jasmine Neal, Leslie A. Andritsos, James S. Blachly, Narendranath Epperla, Zeinab El Boghdadly, Michael R. Grever, Kerry A. Rogers

Blood (2022) 140 (Supplement 1): 9361–9362.

https://doi.org/10.1182/blood-2022-156720

Published: 2022

Journal Articles

Impact of Monoclonal Protein at Diagnosis on Outcomes in Patients with Marginal Zone Lymphoma: A Multicenter Cohort Study

Narendranath Epperla, Qiuhong Zhao, Lauren Shea, Reem Karmali, Pallawi Torka, Timothy Seijung Oh, Andrea Anampa-Guzman, Ximena Jordan Bruno, Elvira Umyarova, Kathryn Lindsey, Irl Brian Greenwell, Sayan Mullick Chowdhury, Yazeed Sawalha, Beth Christian, Natalie S. Grover, Nancy L. Bartlett, Adam J. Olszewski

Blood (2022) 140 (Supplement 1): 420–422.

https://doi.org/10.1182/blood-2022-158771

Published: 2022

Journal Articles

The Co-Occurrence of 1q21+/1q23+ and t(4;14) Abnormalities with Specific Clone Size Is Predictive of Shorter Response to Transplant in Patients with Multiple Myeloma

Michael P. Ozga, Qiuhong Zhao, Naresh Bumma, Ashley E. Rosko, Abdullah Khan, Srinivas Devarakonda, Elvira Umyarova, Don M. Benson, Jr., Francesca Cottini

Blood (2022) 140 (Supplement 1): 9993–9994.

https://doi.org/10.1182/blood-2022-158693

Published: 2022

Journal Articles

Retrospective Analysis of Residual Hairy Cell Leukemia Measured By IHC or Flow Cytometry and Frontline Treatment with Pentostatin on Time to Next Treatment

Andrew Stiff, Qiuhong Zhao, Nilesh Kapoor, Kerry A. Rogers, Mirela Iulia Anghelina, Jasmine Neal, Leslie A. Andritsos, James S. Blachly, Gerard Lozanski, Michael R. Grever, Seema A. Bhat

Blood (2022) 140 (Supplement 1): 6524–6525.

https://doi.org/10.1182/blood-2022-166619

Published: 2022

Journal Articles

Multiple Myeloma Transplant: Examining the Intersection of Access, Age and Race

Ashley E. Rosko, Kaitlyn Dvorak, Qiuhong Zhao, Electra Paskett, Samantha Jaglowski, James L. Fisher, Jessica Krok-Schoen, Francesca Cottini, Abdullah Khan, Srinivas Devarakonda, Naresh Bumma, Elvira Umyarova, Nidhi Sharma, Don M. Benson, Jr., Jesse Plascak

Blood (2022) 140 (Supplement 1): 5170–5171.

https://doi.org/10.1182/blood-2022-164653

Published: 2022

Journal Articles

T-Cell Senescence and Exhaustion Are Associated with Interval Progression of Multiple Myeloma before Autologous Hematopoietic Cell Transplant

Alicia Bao, Ruchi Kudalkar, Jose Rodriguez, Qiuhong Zhao, Nidhi Sharma, Naresh Bumma, Srinivas Devarakonda, Abdullah Khan, Ashley E. Rosko, Elvira Umyarova, Don M. Benson, Jr., Francesca Cottini

Blood (2022) 140 (Supplement 1): 7257–7258.

https://doi.org/10.1182/blood-2022-167226

Published: 2022

Journal Articles

Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)

Joseph Maakaron, Qiuhong Zhao, Jayalakshmi Panicker Balakrishna, Marcin Puto, Wesley Ferguson, Sam Penza, Jonathan E Brammer, Kami J. Maddocks, Yvonne A. Efebera, Ayman Saad, Samantha Jaglowski, Basem M. William

Blood (2021) 138 (Supplement 1): 656.

https://doi.org/10.1182/blood-2021-149580

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

High Incidence of Severe TA-TMA Increases Mortality in adult Allogeneic Transplant recipients: A prospective MIDAS Consortium study

A Phase I Study to Evaluate the Safety and Tolerability of Gemtuzumab Ozogamicin and Midostaurin When Used in Combination with Standard Cytarabine and Daunorubicin Induction for Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia

Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy Is Associated with Inferior Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma

Association between Post-CART Terminal Complement Complex Levels and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)

Building Inroads for Transplant Access: Bridging the Gap for Underserved Patients with Multiple Myeloma

Extended Follow up of a Phase 2 Study of Early Intervention with Lenalidomide in Patients with High-Risk Chronic Lymphocytic Leukemia

Deletion 1p at Time of Diagnosis of Multiple Myeloma Portends Inferior Outcomes

A Randomized Double-Blind Placebo-Controlled Phase II Multi-Center Study of Inflammation Modification of Canakinumab to Prevent Leukemic Progression of Clonal Cytopenias of Unknown Significance (CCUS): Impact Study

A Phase II Study of Clinical Efficacy of Venetoclax in Combination with Azacitidine in Patients with Therapy Related Myelodysplastic Syndrome (t-MDS)

Efficacy of Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Toxicities - a Multicenter Retrospective Analysis

Predictive Score for Utilization of Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

I-DATA Study: Randomized, Sequential, Open-Label Study to Evaluate the Efficacy of IDH Targeted/Non- Targeted Versus Non-Targeted/IDH-Targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated Adult AML Patients Not Candidates for Intensive Induction Therapy

Ventricular arrhythmias and sudden death events following acalabrutinib initiation

Incidence, Description, and Timing of Serious or Opportunistic Infections in Patients with Hairy Cell Leukemia Treated with Purine Nucleoside Analogues

Impact of Monoclonal Protein at Diagnosis on Outcomes in Patients with Marginal Zone Lymphoma: A Multicenter Cohort Study

The Co-Occurrence of 1q21+/1q23+ and t(4;14) Abnormalities with Specific Clone Size Is Predictive of Shorter Response to Transplant in Patients with Multiple Myeloma

Retrospective Analysis of Residual Hairy Cell Leukemia Measured By IHC or Flow Cytometry and Frontline Treatment with Pentostatin on Time to Next Treatment

Multiple Myeloma Transplant: Examining the Intersection of Access, Age and Race

T-Cell Senescence and Exhaustion Are Associated with Interval Progression of Multiple Myeloma before Autologous Hematopoietic Cell Transplant

Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only